Harmony Biosciences Holdings, Inc.
Total Trades
94
Buys
0
Sells
66
Largest Trade
N/A
Insiders
9
Institutional Funds
256
Inst. Value
$1M+
Activist Filings
20
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Kapadia Sandip | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 4K | $37.15 | Jan 29, 2026 |
| Kapadia Sandip | CHIEF FINANCIAL OF… | SELL | $500K+ | 21K | $35.92 | Jan 21, 2026 |
| Dayno Jeffrey M. | PRESIDENT, CEO | EXERCISE | $100K–$500K | 20K | $8.22 | Dec 17, 2025 |
| Dayno Jeffrey M. | PRESIDENT, CEO | SELL | $1M+ | 26K | $40.11 | Dec 17, 2025 |
| Kapadia Sandip | CHIEF FINANCIAL OF… | SELL | $500K+ | 20K | $39.54 | Dec 9, 2025 |
| Kapadia Sandip | CHIEF FINANCIAL OF… | EXERCISE | $500K+ | 20K | $29.03 | Dec 9, 2025 |
| Kapadia Sandip | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 3K | $35.00 | Nov 25, 2025 |
| Kapadia Sandip | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 7K | $32.54 | Apr 3, 2025 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | EXERCISE | $100K–$500K | 16K | $25.47 | Jan 28, 2025 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | SELL | $500K+ | 15K | $37.38 | Jan 28, 2025 |
| Kapadia Sandip | CHIEF FINANCIAL OF… | EXERCISE | N/A | 4K | — | Jan 28, 2025 |
| Kapadia Sandip | CHIEF FINANCIAL OF… | SELL | $50K–$100K | 2K | $38.05 | Jan 28, 2025 |
| Dayno Jeffrey M. | PRESIDENT, CEO | EXERCISE | $100K–$500K | 19K | $8.22 | Jan 23, 2025 |
| Dayno Jeffrey M. | PRESIDENT, CEO | SELL | $500K+ | 19K | $40.13 | Jan 23, 2025 |
| Kapadia Sandip | CHIEF FINANCIAL OF… | SELL | $1M+ | 25K | $40.18 | Jan 23, 2025 |
| Kapadia Sandip | CHIEF FINANCIAL OF… | EXERCISE | $500K+ | 25K | $29.03 | Jan 23, 2025 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | SELL | $1M+ | 31K | $37.51 | Jan 22, 2025 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | EXERCISE | $1M+ | 31K | $33.44 | Jan 22, 2025 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | SELL | $100K–$500K | 11K | $37.01 | Jan 16, 2025 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | EXERCISE | $100K–$500K | 11K | $33.44 | Jan 16, 2025 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | SELL | $100K–$500K | 7K | $37.04 | Jan 15, 2025 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | EXERCISE | $100K–$500K | 7K | $33.44 | Jan 15, 2025 |
| Valor IV Pharma Holdings, LLC | 10% Owner | SELL | $1M+ | 4.6M | $30.30 | Nov 5, 2024 |
| Marshman Fund Trust II | 10% Owner | SELL | $1M+ | 4.6M | $30.30 | Nov 5, 2024 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | SELL | $500K+ | 21K | $40.47 | Oct 31, 2024 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | EXERCISE | $500K+ | 21K | $24.00 | Oct 31, 2024 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | SELL | $1M+ | 36K | $35.06 | Oct 7, 2024 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | SELL | $15K–$50K | 400 | $40.19 | Oct 2, 2024 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | EXERCISE | $1K–$15K | 400 | $24.00 | Oct 2, 2024 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | SELL | $1M+ | 36K | $40.03 | Oct 1, 2024 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | EXERCISE | $500K+ | 36K | $24.00 | Oct 1, 2024 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | EXERCISE | $1K–$15K | 200 | $24.00 | Sep 30, 2024 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | SELL | $1K–$15K | 200 | $40.05 | Sep 30, 2024 |
| Nielsen Jack | Director | SELL | $100K–$500K | 3K | $59.96 | Dec 17, 2022 |
| Wicki Andreas | Director | SELL | $1M+ | 29K | $60.31 | Dec 15, 2022 |
| Nielsen Jack | Director | SELL | $1M+ | 111K | $60.16 | Dec 10, 2022 |
| Wicki Andreas | Director | SELL | $1M+ | 78K | $61.23 | Dec 8, 2022 |
| Serafin Andrew | CHIEF STRATEGY OFF… | SELL | $1M+ | 38K | $60.13 | Dec 5, 2022 |
| Serafin Andrew | CHIEF STRATEGY OFF… | EXERCISE | $100K–$500K | 38K | $8.22 | Dec 5, 2022 |
| Nielsen Jack | Director | SELL | $1M+ | 130K | $59.29 | Dec 2, 2022 |
| Nielsen Jack | Director | SELL | $1M+ | 78K | $57.27 | Nov 23, 2022 |
| Wicki Andreas | Director | SELL | $1M+ | 51K | $59.31 | Nov 17, 2022 |
| Nielsen Jack | Director | SELL | $1M+ | 158K | $57.58 | Nov 15, 2022 |
| Wicki Andreas | Director | SELL | $1M+ | 129K | $58.89 | Nov 11, 2022 |
| Wicki Andreas | Director | SELL | $1M+ | 577K | $59.09 | Nov 5, 2022 |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFI… | EXERCISE | $100K–$500K | 15K | $8.22 | Nov 4, 2022 |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFI… | SELL | $500K+ | 15K | $60.02 | Nov 4, 2022 |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFI… | SELL | $500K+ | 15K | $55.10 | Nov 2, 2022 |
| Dayno Jeffrey M. | CHIEF MEDICAL OFFI… | EXERCISE | $100K–$500K | 15K | $8.22 | Nov 2, 2022 |
| Dierks Jeffrey | CHIEF COMMERCIAL O… | SELL | $500K+ | 12K | $44.68 | Oct 4, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 256 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| AMERICAN CENTURY COMPANIES INC | 1.8M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 1.7M | $1M+ | SH |
| STATE STREET CORP | 1.7M | $1M+ | SH |
| LSV ASSET MANAGEMENT | 1.7M | $1M+ | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.5M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.1M | $1M+ | SH |
| SG Americas Securities, LLC | 962K | $1M+ | SH |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 539K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 525K | $1M+ | SH |
| NOMURA HOLDINGS INC | 510K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 418K | $1M+ | SH |
| Tieton Capital Management, LLC | 297K | $1M+ | SH |
| Pacer Advisors, Inc. | 290K | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 290K | $1M+ | SH |
| CAPITAL MANAGEMENT CORP /VA | 282K | $1M+ | SH |
| ROYCE & ASSOCIATES LP | 278K | $1M+ | SH |
| CX Institutional | 276K | $1M+ | SH |
| VICTORY CAPITAL MANAGEMENT INC | 273K | $1M+ | SH |
| BlackRock, Inc. | 258K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 5, 2026
5.4%
3.1M shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
SC 13G/A · Nov 5, 2025
6.7%
3.8M shares
SC 13G/A · Apr 29, 2025
10.1%
5.8M shares
SC 13G/A · Feb 12, 2025
11.6%
6.6M shares
SC 13G/A · Feb 10, 2025
10.6%
6.1M shares
SC 13G/A · Feb 5, 2025
12.2%
7.0M shares
SC 13G/A · Jan 31, 2025
8.3%
4.7M shares
SC 13G/A · Feb 14, 2024
19.2%
11.2M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
6.3%
3.7M shares
SC 13G/A · Jan 24, 2024
10.2%
6.0M shares
SC 13G/A · Oct 6, 2023
10.2%
6.1M shares
HBM Healthcare Investments (Cayman) Ltd.
SC 13G/A · Feb 14, 2023
3.6%
2.1M shares
SC 13G/A · Feb 13, 2023
4.3%
2.6M shares
SC 13G/A · Feb 13, 2023
18.9%
11.2M shares
SC 13G/A · Feb 3, 2023
8.2%
4.9M shares
venBio Global Strategic Fund II, L.P.
SC 13G/A · Feb 14, 2022
4.7%
2.7M shares
SC 13G/A · Feb 11, 2022
7.4%
4.3M shares
HBM Healthcare Investments (Cayman) Ltd.
SC 13G/A · Feb 11, 2022
7.8%
4.5M shares
SC 13G/A · Feb 10, 2022
19.2%
11.2M shares